EZZ Life Science Holdings Limited (ASX:EZZ)

Market Cap	23.53M -75.7%
Revenue (ttm)	61.40M -18.2%
Net Income	2.89M -67.9%
EPS	0.06 -69.8%
Shares Out	47.07M
PE Ratio	8.15
Forward PE	n/a
Dividend	0.04 (8.60%)
Ex-Dividend Date	n/a

Volume	22,357
Open	0.4650
Previous Close	0.4650
Day's Range	0.4650 - 0.5000
52-Week Range	0.3550 - 3.3800
Beta	0.94
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About EZZ Life Science Holdings

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consumer distribution through e-commerce store. The company provides health and wellness products under the EZZ brand. It also offers its products online. Th...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EZZ

Financial Performance

In fiscal year 2025, EZZ Life Science Holdings's revenue was 66.87 million, an increase of 0.65% compared to the previous year's 66.44 million. Earnings were 6.73 million, a decrease of -3.36%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 5, 2026

Data Sources Report a data error